Related Experiment Video
Updated: May 11, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
Temporary Peripheral Nerve Stimulation for the Treatment of Greater Occipital Neuralgia
Royce Copeland1, Angela Nwankwo1, Emanuel Narcis Husu1
1Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX.
Background:
Greater occipital neuralgia (GON), a cause of chronic headaches, can be debilitating and vastly affect one's quality of life. Recent strides in comprehending the pathophysiology of GON and the ongoing evolution of approaches to the condition's treatment have led to the pursuit of more effective interventions. Among these, temporary peripheral nerve stimulation (PNS) devices have surfaced as an avenue for management, presenting a minimally invasive yet highly efficient alternative in treating other chronic pain conditions. This study discusses a case of GON successfully managed with temporary (60-day) PNS.
Case Report:
A 35-year-old man presented with a nearly 8-month history of intractable headaches without any inciting event along the left greater occipital nerve distribution. The patient underwent a series of 2 diagnostic GON blocks and experienced 90% pain relief. A 60-day PNS device was implanted to treat the patient's left-side GON, and during the 6-month period, the patient received 75% pain with no complications.
Conclusions:
Temporary PNS is a promising treatment for painful mononeuropathies. Most PNS devices are implanted permanently to provide benefits, but this new development allows temporary stimulation devices to manage chronic pain. This case demonstrates another potential therapeutic option for pain management providers to alleviate pain in patients suffering from GON.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

